The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma
European Journal of Nuclear Medicine & Molecular Imaging, 05/12/2011
Sorensen M et al. – 2–[18F]fluoro–2–deoxy–D–galactose (FDGal) PET/CT has great clinical potential as a PET tracer for detection of extra– but also intrahepatic hepatocellular carcinoma (HCC). In the present study, the specificity of FDGal PET/CT was 100%, which is very promising but needs to be confirmed in a larger, prospective study.

![print MDLinx article: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma print mdlinx article: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma](/img/articles-print-off.png)
![email MDLinx article: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma email mdlinx article: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma](/img/articles-email-off.png)
![save MDLinx article to My Library: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma save mdlinx article to my library: The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma](/img/articles-save-to-my-library-off.png)